The prediction of bleeding in in-hosptial patients using anticoagulants. Het voorspellen van bloedingen bij patienten met antistollingsmedicatie in het ziekenhuis.

Development of a clinical prediction model for bleeding complications in hospitalized patients using coumarins.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21983

Enrollment

300

Registered

2010-12-31

Start date

2010-07-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eng: bleeding complications while using coumarins (vitamin K antagonist) keywords: bleeding - coumarin - vitamin K antagonist - prediction model - risk factor Dutch: Bloedingscomplicaites bij gebruik van coumarines (vitamine K antagonisten) bloeding - coumarine - vitamine K antagonist - voorspelmodel - risico factor

Interventions

It is a nested case control study. Identification of risk factors for bleeding complications in patients using coumarins. With these risk factors a clinical prediction model for high risk of bleeding

Eligibility

Inclusion criteria

Inclusion criteria: Hospitalized patients => 18 yr with an prescription for a coumarin within the 4-year period 2006-2009.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
INR > 4.5.	—

Secondary

Measure	Time frame
One of the following prescriptions: 1. Vitamin K prescription; 2. PCC prescription; 3. Tranexamic acid prescription; 4. Blood transfusion (platelets, plasma, erythrocytes). Or death.	—

Contacts

Public ContactA.D. Lindemans

's Gravendijkwal 230

A.Lindemans@erasmusmc.nl+31 (0)10 7033202

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)